Therefore, we speculate that the hyperbilirubinemia in the NIL group may be due to the low AVP circulating levels, which were not enough to activate the AVP receptor signaling mechanisms that mediate the hepatocyte bilirubin excretion. The gene discussed is AVP; the disease is Hyperbilirubinemia.